The mixed lineage leukemia (MLL) fusion-associated gene AF4 promotes CD133 transcription.
暂无分享,去创建一个
[1] Frank Speleman,et al. Imperfect protection: NEPA at 35 years. , 2004, Genome Biology.
[2] J. Marks,et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells , 2009, Oncogene.
[3] S. Rafii,et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. , 2004, Blood.
[4] P. Hadwiger,et al. Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. , 2005, Blood.
[5] S. Bidlingmaier,et al. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells , 2008, Journal of Molecular Medicine.
[6] Kevin R Brown,et al. Essential gene profiles in breast, pancreatic, and ovarian cancer cells. , 2012, Cancer discovery.
[7] Anne-Claude Gingras,et al. A Lentiviral Functional Proteomics Approach Identifies Chromatin Remodeling Complexes Important for the Induction of Pluripotency* , 2010, Molecular & Cellular Proteomics.
[8] Xiaobo Xia,et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. , 2008, Cancer cell.
[9] J. Herman,et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. , 2008, Cancer research.
[10] T. Haferlach,et al. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping. , 2001, Haematologica.
[11] M. Cleary,et al. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. , 2010, Cancer cell.
[12] Zhongsheng You,et al. DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints. , 2010, Trends in cell biology.
[13] S. Kohsaka,et al. Promoter hypomethylation regulates CD133 expression in human gliomas , 2008, Cell Research.
[14] G. Scambia,et al. Targeting CD133 antigen in cancer , 2009, Expert opinion on therapeutic targets.
[15] O. Fodstad,et al. The Stem Cell‐Associated Antigen CD133 (Prominin‐1) Is a Molecular Therapeutic Target for Metastatic Melanoma , 2008, Stem cells.
[16] G. Stassi,et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. , 2010, Cancer research.
[17] J. Moffat,et al. CD133 Protein N-Glycosylation Processing Contributes to Cell Surface Recognition of the Primitive Cell Marker AC133 Epitope* , 2011, The Journal of Biological Chemistry.
[18] Richard A Young,et al. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. , 2008, Genes & development.
[19] T. Taga,et al. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks , 2010, Molecular Cancer.
[20] Anne E Carpenter,et al. A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen , 2006, Cell.
[21] P. Kearns,et al. Expression of CD133 on leukemia-initiating cells in childhood ALL. , 2009, Blood.